Design Therapeutics Stock Investor Sentiment
| DSGN Stock | USD 3.66 0.23 5.91% |
About 56% of all Design Therapeutics' investors are looking to take a long position. The analysis of the overall investor sentiment regarding Design Therapeutics suggests that some traders are interested. Design Therapeutics' investor sentiment overview provides quick insight into current market opportunities from investing in Design Therapeutics. The current market sentiment, together with Design Therapeutics' historical and current headlines, can help investors time the market. In addition, many technical investors use Design Therapeutics stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Design Therapeutics stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Design daily returns and investor perception about the current price of Design Therapeutics as well as its diversification or hedging effects on your existing portfolios.
Design |
Design Therapeutics Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Design Therapeutics can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Far too much social signal, news, headlines, and media speculation about Design Therapeutics that are available to investors today. That information is available publicly through Design media outlets and privately through word of mouth or via Design internal channels. However, regardless of the origin, that massive amount of Design data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Design Therapeutics news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Design Therapeutics relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Design Therapeutics' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Design Therapeutics alpha.
Design Therapeutics Performance against NYSE Composite
Price Growth (%) |
| Timeline |
1 | Title Brainstorm Cell Therapeutics to Present Innovative Phase 3B Trial Design for NurOwn in Treating ALS at MDA ... - Best Stocks | 02/27/2024 |
2 | Design Therapeutics Set to Announce Earnings on Tuesday - MarketBeat | 03/11/2024 |
3 | Disposition of 175000 shares by Kim Jae B. of Design Therapeutics at 2.54 subject to Rule 16b-3 | 03/13/2024 |
4 | Acquisition by Xu Stella of 44398 shares of Design Therapeutics subject to Rule 16b-3 | 03/14/2024 |
5 | Design Therapeutics GAAP EPS of -0.21 beats by 0.11 | 03/19/2024 |
6 | DSGN Stock Earnings Design Therapeutics Beats EPS for Q4 2023 | 03/20/2024 |
7 | Acquisition by Schmid John P. of 9156 shares of Design Therapeutics at 3.6187 subject to Rule 16b-3 | 03/22/2024 |
8 | Design therapeutics director buys shares worth over 99k | 03/25/2024 |
9 | Independent Director of Design Therapeutics Picks Up 88 percent More Stock | 03/27/2024 |
10 | Disposition of 7236938 shares by Quan Venture Fund Ii, L.p. of Design Therapeutics subject to Rule 16b-3 | 04/11/2024 |
Check out Design Therapeutics Hype Analysis, Design Therapeutics Correlation and Design Therapeutics Performance. To learn how to invest in Design Stock, please use our How to Invest in Design Therapeutics guide.Note that the Design Therapeutics information on this page should be used as a complementary analysis to other Design Therapeutics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Complementary Tools for Design Stock analysis
When running Design Therapeutics' price analysis, check to measure Design Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Design Therapeutics is operating at the current time. Most of Design Therapeutics' value examination focuses on studying past and present price action to predict the probability of Design Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Design Therapeutics' price. Additionally, you may evaluate how the addition of Design Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| AI Investment Finder Use AI to screen and filter profitable investment opportunities |
Is Design Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Design Therapeutics. If investors know Design will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Design Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.19) | Revenue Per Share 0.001 | Return On Assets (0.15) | Return On Equity (0.22) |
The market value of Design Therapeutics is measured differently than its book value, which is the value of Design that is recorded on the company's balance sheet. Investors also form their own opinion of Design Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Design Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Design Therapeutics' market value can be influenced by many factors that don't directly affect Design Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Design Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Design Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Design Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.